Eyenovia, Inc. ( EYEN) - Key Metrics
Stock symbol EYEN is outdated, potentially delisted? Maybe it is available on other exchange?
EYEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $0.02 | -$17.50 | -$5.36 | -$5.36 |
| 2024Q3 | $0 | -$9.07 | -$6.84 | -$6.84 |
| 2024Q2 | $0.03 | -$13.87 | -$10.26 | -$10.32 |
| 2024Q1 | $0.01 | -$15.62 | -$14.15 | -$14.31 |
| 2023Q4 | $0 | -$11.70 | -$9.28 | -$9.50 |
EYEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -0.17 |
| 2024Q3 | ? | -1.14 |
| 2024Q2 | ? | -0.98 |
| 2024Q1 | ? | -1.26 |
| 2023Q4 | ? | -3.56 |
EYEN
Price: $10.56
52 week price:
Earnings Per Share: -42.65 USD
P/E Ratio: -0.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 305981
Market Capitalization: 80.8 million